Eyes On Eyecare

Just over 11 months after submitting a De Novo request for its lead product, LumiThera, Inc. announced the FDA has authorized marketing of the Valeda Light Delivery System (LDS) for the treatment of patients with dry age-related macular degeneration (AMD). Learn more on Glance: https://lnkd.in/d6sXaz9X #GlanceNews #eyecare Tracy Puckett 

Join experts Damon Dierker, OD, FAAO, and Dr. Mahnia Madan, OD, FAAO, as they dive into evaluating DED therapies and when it’s time to adjust treatments. Hear their insights and real-life examples. Get started here: https://hubs.ly/Q02WgqdD0 #eyecare #dryeye

Wait, they said WHAT?! Watch as a KOL reacts to real-life contact lens chats, and let’s just say… things get interesting! https://hubs.ly/Q02Wqb7B0

Recent interim findings evaluating the use of Brightstar Therapeutics’ proprietary anterior keratoplasty procedure support this solution-based approach for treating limbal stem cell deficiency (LSCD). The data was presented by Joshua Hou, MD, Brightstar’s chief medical officer, during the Eye Bank Association of America and the Cornea Society’s Cornea and Eye Banking Forum last month. Learn more on Glance: https://lnkd.in/ehUGxRuE #GlanceNews #eyecare

Looking for relief for your dry eye patients? Get the clinical data that influenced how Josh Johnston, OD, FAAO, formulates his strategy to combat inflammation. Click to read more: https://hubs.ly/Q02WD1NP0 #dryeyedisease #DED #optometry #expertinsight #eyesonpartner PM-US-CQA-1479

In the latest Ready, Set, Retina, Jessica Haynes, OD, FAAO, walks through a complex RPE tear case and how she would handle it. With insights on treatment, risks, and unique imaging findings, this episode offers a deeper understanding of RPE tears for ECPs. Learn more here: https://hubs.ly/Q02Wqb180 #ReadySetRetina #optometrist 

Genentech, Inc., a member of the Roche Group, reported positive topline findings from the phase 4 ELEVATUM trial evaluating VABYSMO (faricimab-svoa) for treating diabetic macular edema (DME) among a specific subset of patients: underrepresented racial and ethnic groups. Learn more on Glance: https://lnkd.in/efJdrvuy #GlanceNews #eyecare Rachel Inboden

We surveyed 249 optometrists to bring you the latest insights into contact lens preferences, prescribing trends, and the challenges ODs are facing today. The 2024 Contact Lens Report is officially LIVE! Ready to dive into the trends shaping optometry this year? Get a sneak peek below, then download the full report for all the details: https://hubs.ly/Q02RKJzS0 #eyecare

As part of its ongoing efforts to promote daily eye health, myze has announced the launch of its first branded product: The Daily Lid Wipe. Learn more on Glance: https://lnkd.in/eenMPJQH #GlanceNews #eyecare Scott Tannenbaum

At the American Academy of Ophthalmology (AAO) earlier this month, Haag-Streit showcased the METIS, a new ophthalmic microscope system. Making its U.S. debut, the METIS microscope is designed to provide advanced optics for both clarity and precision during ophthalmic surgeries. Learn more on Glance: https://lnkd.in/eZ66jWkc #GlanceNews #eyecare Jeff Sieve